Operating Margin of SUPERNUS PHARMACEUTICALS, INC. from 31 Dec 2011 to 31 Mar 2020
- Taxonomy & unit
- ratio: %
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Summary
-
SUPERNUS PHARMACEUTICALS, INC. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2011 to 31 Mar 2020.
- SUPERNUS PHARMACEUTICALS, INC. Operating Margin for the quarter ending 31 Mar 2020 was 38%, a 10% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. annual Operating Margin for 2019 was 38%, a 7.1% increase from 2018.
- SUPERNUS PHARMACEUTICALS, INC. annual Operating Margin for 2018 was 35%, a 7.3% increase from 2017.
- SUPERNUS PHARMACEUTICALS, INC. annual Operating Margin for 2017 was 33%, a 31% increase from 2016.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
SUPERNUS PHARMACEUTICALS, INC. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2020 | 38% | +3.5% | +10% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | 38% | +2.5% | +7.1% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | 36% | -0.27% | -0.74% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | 36% | +1% | +3% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | 34% | +0.22% | +0.64% | 01 Jan 2019 | 31 Mar 2019 |
| Q4 2018 | 35% | +2.4% | +7.3% | 01 Oct 2018 | 31 Dec 2018 |
| Q3 2018 | 36% | +6.9% | +23% | 01 Jul 2018 | 30 Sep 2018 |
| Q2 2018 | 34% | +3.2% | +10% | 01 Apr 2018 | 30 Jun 2018 |
| Q1 2018 | 34% | +5.8% | +20% | 01 Jan 2018 | 31 Mar 2018 |
| Q4 2017 | 33% | +7.7% | +31% | 01 Oct 2017 | 31 Dec 2017 |
| Q3 2017 | 30% | +6.2% | +26% | 01 Jul 2017 | 30 Sep 2017 |
| Q2 2017 | 31% | +14% | +80% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | 28% | +14% | +98% | 01 Jan 2017 | 31 Mar 2017 |
| Q4 2016 | 25% | +11% | +78% | 01 Oct 2016 | 31 Dec 2016 |
| Q3 2016 | 23% | +9.9% | +74% | 01 Jul 2016 | 30 Sep 2016 |
| Q2 2016 | 17% | +7% | +67% | 01 Apr 2016 | 30 Jun 2016 |
| Q1 2016 | 14% | +3.4% | +32% | 01 Jan 2016 | 31 Mar 2016 |
| Q4 2015 | 14% | +20% | 01 Oct 2015 | 31 Dec 2015 | |
| Q3 2015 | 13% | +44% | 01 Jul 2015 | 30 Sep 2015 | |
| Q2 2015 | 10% | +86% | 01 Apr 2015 | 30 Jun 2015 | |
| Q1 2015 | 11% | +285% | 01 Jan 2015 | 31 Mar 2015 | |
| Q4 2014 | -5.7% | +509% | +99% | 01 Oct 2014 | 31 Dec 2014 |
| Q3 2014 | -30% | 01 Jul 2014 | 30 Sep 2014 | ||
| Q2 2014 | -76% | 01 Apr 2014 | 30 Jun 2014 | ||
| Q1 2014 | -274% | 01 Jan 2014 | 31 Mar 2014 | ||
| Q4 2013 | -515% | 01 Oct 2013 | 31 Dec 2013 |
SUPERNUS PHARMACEUTICALS, INC. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2019 | 38% | +2.5% | +7.1% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | 35% | +2.4% | +7.3% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | 33% | +7.7% | +31% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | 25% | +11% | +78% | 01 Jan 2016 | 31 Dec 2016 |
| 2015 | 14% | +20% | 01 Jan 2015 | 31 Dec 2015 | |
| 2014 | -5.7% | +509% | +99% | 01 Jan 2014 | 31 Dec 2014 |
| 2013 | -515% | +2334% | +82% | 01 Jan 2013 | 31 Dec 2013 |
| 2012 | -2849% | +1852% | +39% | 01 Jan 2012 | 31 Dec 2012 |
| 2011 | -4701% | 01 Jan 2011 | 31 Dec 2011 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.